Compare the BestGLP-1 Weight Loss Providers

GLP-1 receptor agonists have transformed the market of medical weight loss treatment. Medications like semaglutide and tirzepatide work by mimicking a natural hormone called glucagon like peptide 1 that your body produces in response to eating.

These medications slow stomach emptying, reduce appetite, and help regulate blood sugar levels. Clinical trials have shown remarkable results, with patients losing 15 to 22 percent of their body weight over 12 to 18 months.

Understanding how these medications work helps set realistic expectations and maximize results during treatment. The appetite reduction many patients experience makes it easier to maintain the calorie deficit needed for weight loss.

Semaglutide, sold under brand names Wegovy and Ozempic, targets the GLP-1 receptor to reduce appetite and promote weight loss. Tirzepatide, marketed as Zepbound and Mounjaro, takes a dual approach by targeting both GLP-1 and GIP receptors, which may provide even greater weight loss results.

Both medications are administered as weekly injections that patients give themselves at home. Clinical studies show tirzepatide produces slightly higher average weight loss, but individual results vary.

Your telehealth provider can help determine which medication best suits your health profile and weight loss goals. Factors like insurance coverage, cost, and personal preference also influence the choice.

Brand-name GLP-1 medications cost 1,000 to 1,400 dollars per month at list price, but several affordable pathways exist through telehealth providers. Wegovy lists at 1,349 dollars per month and Zepbound at 1,059 dollars per month without insurance. Compounded semaglutide, which contains the same active ingredient prepared by licensed compounding pharmacies, costs 199 to 500 dollars per month — a savings of 70 to 85 percent. The FDA permits compounding during drug shortages, and semaglutide has been on the FDA shortage list since March 2022.

Manufacturer savings programs can reduce brand-name costs for commercially insured patients. Novo Nordisk offers the Wegovy savings card covering up to 500 dollars per fill, and Eli Lilly offers Zepbound at 25 dollars per month for eligible patients with commercial insurance. Patient assistance programs provide free medication for qualifying low-income individuals. Older medications like phentermine cost 20 to 50 dollars per month and remain effective for short-term weight loss.

When comparing options, consider total program costs including medication, consultations, shipping, and ongoing monitoring. Platforms like hims offer compounded semaglutide from 199 dollars per month all-inclusive. Ro starts at 299 dollars per month with complete clinical support. HSA and FSA accounts can cover weight loss medication costs when prescribed for a medical condition. Our comparison table shows current pricing across all reviewed platforms.

To qualify for GLP-1 weight loss medication through telehealth, you typically need a body mass index of 30 or higher, which is classified as obesity. Patients with a BMI of 27 or higher may also qualify if they have weight related health conditions like type 2 diabetes, high blood pressure, high cholesterol, or sleep apnea.

Your provider will screen for contraindications including personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome, history of pancreatitis, and pregnancy.

A thorough evaluation ensures GLP-1 treatment is safe and appropriate for your situation. Most telehealth platforms include this screening as part of their initial consultation process.

Starting GLP-1 weight loss medication involves a gradual dosing schedule that minimizes side effects while building to therapeutic levels. Most protocols begin with a lower dose for the first four weeks, then increase monthly until reaching the target dose.

Common side effects during the initial weeks include nausea, constipation, and decreased appetite. These effects typically improve as your body adjusts to the medication.

Most patients notice reduced hunger and cravings within the first one to two weeks, with significant weight loss becoming apparent after two to three months of treatment.

While GLP-1 medications significantly reduce appetite and promote weight loss on their own, combining them with healthy lifestyle changes maximizes results and supports long term success. Focus on protein rich meals that provide satiety with less volume since your appetite will be reduced.

Regular physical activity helps preserve muscle mass during weight loss and improves overall health. Stay well hydrated because some people experience decreased thirst on these medications.

Many telehealth weight loss programs include nutrition coaching and exercise guidance alongside medication prescriptions. These complete approaches tend to produce better long term outcomes.

Most side effects from GLP-1 medications are gastrointestinal and occur primarily during the dose escalation phase. Nausea affects many patients initially but usually improves within a few weeks.

Eating smaller meals, avoiding fatty or greasy foods, and staying upright after eating can help minimize discomfort. Constipation responds well to increased fiber and water intake.

More serious side effects are rare but include pancreatitis, gallbladder problems, and allergic reactions. Contact your provider immediately if you experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction.

Getting weight loss medication through telehealth begins with a complete health assessment designed to evaluate your eligibility and identify the safest treatment option. The process typically involves completing a detailed questionnaire covering your weight history, BMI calculation, existing health conditions (diabetes, hypertension, sleep apnea), current medications, and weight loss goals. According to the CDC, 41.9 percent of US adults have obesity (BMI 30 or higher), making weight loss one of the most common telehealth consultation categories.

A licensed provider reviews your assessment and conducts a video or asynchronous consultation within 24 to 48 hours. They evaluate whether GLP-1 medications, compounded alternatives, or other treatments are appropriate based on your health profile. If you qualify, dosing begins at the lowest level and increases gradually over 16 to 20 weeks to minimize gastrointestinal side effects. Your provider creates a personalized treatment plan that may include nutritional guidance and activity recommendations.

After starting treatment, expect monthly check-ins during the initial dose escalation period, then quarterly follow-ups once you reach maintenance dosing. Telehealth platforms track your weight, side effects, and health markers digitally. Most providers include these follow-ups in subscription pricing. The entire process from initial assessment to medication delivery typically takes 5 to 10 days.

One important consideration with GLP-1 weight loss medication is what happens after treatment ends. Studies show that patients who stop taking these medications often regain weight over time, which is why many providers recommend ongoing treatment for sustained results.

However, the lifestyle habits developed during treatment, including healthier eating patterns and regular exercise, can help maintain some of the weight loss. Some patients transition to lower maintenance doses rather than stopping completely.

Discussing long term plans with your telehealth provider helps set realistic expectations and develop a sustainable strategy.

When selecting a telehealth weight loss program, consider factors beyond just medication pricing. Key differentiators include the medications offered (brand-name vs compounded vs non-GLP-1), provider qualifications (board-certified obesity medicine specialists vs general practitioners), clinical support level (metabolic coaching, nutritional guidance, behavioral therapy), and insurance acceptance. According to the Obesity Medicine Association, programs with multidisciplinary support produce 5 to 10 percent greater weight loss compared to medication-only approaches.

Compare program structures carefully. Some platforms like Calibrate offer complete programs including medication, coaching, and metabolic testing from 135 to 199 dollars per month. Platforms like hims focus on affordable medication access from 199 dollars per month with provider check-ins. Ro provides a middle ground with clinical support and compounded options from 299 dollars per month. Insurance-accepting platforms like PlushCare and Sesame Care may reduce your out-of-pocket costs significantly.

Red flags to watch for include programs that guarantee specific weight loss amounts, offer medication without a medical consultation, or use non-licensed providers. Legitimate programs employ licensed physicians or nurse practitioners, use licensed pharmacies, and provide ongoing medical oversight. Check state availability before signing up, as not all platforms operate in every state. Our comparison table ranks programs across these criteria with current verified pricing.